Co-Diagnostics, Inc.

Co-Diagnostics, Inc.verified

CODX

Price:

$0.7451

Market Cap:

$23.79M

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify gen...[Read more]

Industry

Medical - Devices

IPO Date

2017-07-12

Stock Exchange

NASDAQ

Ticker

CODX

The Enterprise Value as of December 2024 (TTM) for Co-Diagnostics, Inc. (CODX) is 15.36M

According to Co-Diagnostics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.36M. This represents a change of -37.83% compared to the average of 24.71M of the last 4 quarters.

Co-Diagnostics, Inc. (CODX) Historical Enterprise Value (quarterly & annually)

How has CODX Enterprise Value performed in the past?

The mean historical Enterprise Value of Co-Diagnostics, Inc. over the last ten years is 69.50M. The current 15.36M Enterprise Value has changed 2.11% with respect to the historical average. Over the past ten years (40 quarters), CODX's Enterprise Value was at its highest in in the June 2020 quarter at 515.17M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

69.50M

Median

51.06M

Minimum

14.10M

Maximum

205.52M

Co-Diagnostics, Inc. (CODX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Co-Diagnostics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.36%

Maximum Annual Enterprise Value = 205.52M

Minimum Annual Increase = -66.50%

Minimum Annual Enterprise Value = 14.10M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202327.10M-52.20%
202256.70M-66.50%
2021169.24M-17.65%
2020205.52M1.36%
201914.10M-27.89%
201819.56M-22.99%
201725.40M-61.89%
201666.66M2.17%
201565.24M43.63%

Co-Diagnostics, Inc. (CODX) Average Enterprise Value

How has CODX Enterprise Value performed in the past?

The current Enterprise Value of Co-Diagnostics, Inc. (CODX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

84.35M

5-year avg

94.53M

10-year avg

69.50M

Co-Diagnostics, Inc. (CODX) Enterprise Value vs. Peers

How is CODX’s Enterprise Value compared to its peers?

Co-Diagnostics, Inc.’s Enterprise Value is greater than Heart Test Laboratories, Inc. (-1145434848.00), greater than NanoVibronix, Inc. (817.63K), less than Rapid Micro Biosystems, Inc. (26.41M), greater than ThermoGenesis Holdings, Inc. (6.40M), greater than Biomerica, Inc. (2.54M), less than Nemaura Medical Inc. (19.51M), greater than Bluejay Diagnostics, Inc. (-3463775.00), less than Movano Inc. (25.99M), less than INVO Bioscience, Inc. (0), less than enVVeno Medical Corporation (33.91M), greater than Tivic Health Systems, Inc. (320.58K), greater than Bone Biologics Corporation (-1275340.00), less than Vivos Therapeutics, Inc. (17.86M), less than Senseonics Holdings, Inc. (315.27M), less than Inogen, Inc. (113.10M), less than ClearPoint Neuro, Inc. (412.44M), less than NeuroPace, Inc. (397.16M), less than Surmodics, Inc. (560.52M), less than CVRx, Inc. (263.52M), greater than NeuroMetrix, Inc. (7.23M), greater than ReShape Lifesciences Inc. (2.60M), less than Inspira Technologies Oxy B.H.N. Ltd. (17.15M), greater than OpGen, Inc. (7.76M),

Build a custom stock screener for Co-Diagnostics, Inc. (CODX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Co-Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Co-Diagnostics, Inc. (CODX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Co-Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Co-Diagnostics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Co-Diagnostics, Inc. (CODX)?

What is the 3-year average Enterprise Value for Co-Diagnostics, Inc. (CODX)?

What is the 5-year average Enterprise Value for Co-Diagnostics, Inc. (CODX)?

How does the current Enterprise Value for Co-Diagnostics, Inc. (CODX) compare to its historical average?